An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
Brock
B
B
Wyeth Lederle Vaccines and Pediatrics, Pearl River, New York, USA.
Mckee
B
B
D000818:Animals; D004165:Diphtheria / Q000517:prevention & control; D004168:Diphtheria Toxoid; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D006168:Guinea Pigs; D006801:Humans; D010567:Pertussis Vaccine; D013745:Tetanus Toxoid
D004168:Diphtheria Toxoid; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D010567:Pertussis Vaccine; D013745:Tetanus Toxoid